Galmed Pharmaceuticals (NASDAQ:GLMD) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report released on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, Maxim Group raised shares of Galmed Pharmaceuticals from a hold rating to a buy rating in a research report on Monday, July 24th. View […]
More Stories
Desert Gold Ventures (CVE:DAU) Shares Up 25% – Still a Buy?
Desert Gold Ventures Inc. (CVE:DAU – Get Free Report)’s share price traded up 25% on Saturday . The stock traded...
Focus Graphite (CVE:FMS) Trading Down 16% – Here’s Why
Shares of Focus Graphite Inc. (CVE:FMS – Get Free Report) dropped 16% on Saturday . The company traded as low...
Borders & Southern Petroleum (LON:BOR) Shares Down 14.5% – Time to Sell?
Shares of Borders & Southern Petroleum plc (LON:BOR – Get Free Report) fell 14.5% during trading on Saturday . The...
Oracle Power (LON:ORCP) Stock Price Down 15% – Here’s Why
Oracle Power plc (LON:ORCP – Get Free Report) fell 15% during trading on Saturday . The company traded as low...
Desert Gold Ventures (CVE:DAU) Shares Up 25% – What’s Next?
Desert Gold Ventures Inc. (CVE:DAU – Get Free Report)’s share price shot up 25% during mid-day trading on Saturday ....
Aimei Health Technology Announces Amendment to Trust Agreement and Promissory Note
Aimei Health Technology Co., Ltd (NASDAQ: AFJKU) recently disclosed, through a Form 8-K filing with the Securities and Exchange Commission,...